Your browser doesn't support javascript.
loading
CHST4 associates with high-abundance immune infiltration in hormone receptor-positive breast cancer.
Liu, Yansong; Hu, Anbang; Shakila, Suborna S; Cheng, Weilun; Wang, Ting; Zhang, Jiarui; Yu, Tianshui; Duan, Yunqiang; Feng, Jianyuan; Ding, Yu; Zhang, Hanyu; Li, Yanling; Li, Mingcui; Rong, Zhiyuan; Shang, Yuhang; Fang, Zhengbo; Liu, Jiangwei; Kong, Fanjing; Guo, Baoliang.
Afiliação
  • Liu Y; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Hu A; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Shakila SS; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Cheng W; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Wang T; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Zhang J; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Yu T; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Duan Y; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Feng J; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Ding Y; Department of General Surgery, Daqing Oilfield General Hospital, Daqing 163316, China.
  • Zhang H; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Li Y; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Li M; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Rong Z; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Shang Y; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Fang Z; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Liu J; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Kong F; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
  • Guo B; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
J Leukoc Biol ; 2024 Aug 30.
Article em En | MEDLINE | ID: mdl-39213175
ABSTRACT
Hormone receptor-positive breast cancer (HR+ BRCA) with high-risk factors such as lymph node metastasis has a relatively poor prognosis. However, the biological basis of tumor cell migration is still poorly understood, especially as some of the metastatic events occur at an early stage. Here, we identified that carbohydrate sulfotransferase 4 (CHST4), which has an important role in lymphocyte homing, was abnormally down-regulated in HR+ BRCA and associated with lymph node metastasis. By enrichment analysis and immune infiltration evaluation, we predicted the potential ability of CHST4 to enhance immune cell infiltration. Then, IHC staining further demonstrated the contribution of CHST4 to the infiltration abundance of CD8+ T cells and CD4+ T cells in HR+ BRCA. IHC staining of MECA-79 further identified the correlation between CHST4 and sulfated perpheral lymphonode vascular addressin (PNAd). Finally, we demonstrated that CHST4 was connected to increased tumor-immune cell communication by analyzing single-cell sequencing data. In summary, our study provided novel insights into the regulation of HR+ BRCA immune infiltration by CHST4.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Leukoc Biol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Leukoc Biol Ano de publicação: 2024 Tipo de documento: Article